AESRX

aesrx-logo

AesRx (ร‡ยฝs-r-ex) is a biopharmaceutical company dedicated to the development of two novel drugs, each of which targets an orphan disease. AesRx's lead program, Aes-103, is a potential breakthrough in the treatment of sickle cell disease. Sickle cell disease is a recessive disorder of the hemoglobin which can cause red blood cells to deform into rigid sickle shapes that block capillaries and other small blood vessels. This blockage can lead to a wide range of serious, sometimes life-threatening, conditions including: chronic hemolytic anemia, chronic pain and acute painful crisis, stroke, acute chest syndrome, and cumulative damage to tissues and organs.

#SimilarOrganizations #People #Website #More

AESRX

Industry:
Biopharma Biotechnology Health Care

Founded:
2008-01-01

Address:
Newton, Massachusetts, United States

Country:
United States

Website Url:
http://www.aesrx.com

Total Employee:
1+

Status:
Active

Contact:
6176636178

Email Addresses:
[email protected]

Total Funding:
3.46 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud OpenResty Google Adsense


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.


Current Advisors List

colin-hill_image

Colin Hill Board of Directors @ AesRx
Board_member

Official Site Inspections

http://www.aesrx.com

  • Host name: 172.67.152.248
  • IP address: 172.67.152.248
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "AesRx"

AesRx - Crunchbase Company Profile & Funding

AesRx (ǽs-r-ex) is a biopharmaceutical company dedicated to the development of two novel drugs, each of which targets an orphan disease. AesRx's lead program, Aes-103, is a potential โ€ฆSee details»

AesRx Company Profile 2024: Valuation, Investors, Acquisition

AesRx General Information Description. Developer of drugs intended to treat sickle cell disease and inflammatory diseases of the lower intestine. The company develops drugs for Sickle cell โ€ฆSee details»

AesRx - Funding, Financials, Valuation & Investors - Crunchbase

AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, Aes-103 and Aes-210, which targets orphan diseases.See details»

Baxter - Baxter Acquires AesRx, LLC, Including Its Investigational ...

DEERFIELD, Ill., July 9, 2014 - Baxter International Inc. (NYSE:BAX) today announced the acquisition of AesRx, LLC, a private U.S. biopharmaceutical company focused on orphan drug โ€ฆSee details»

AesRx - Products, Competitors, Financials, Employees, โ€ฆ

Aesrx is a biopharmaceutical company developing drugs to target sickle cell disease and inflammatory diseases of the lower intestine, including distal ulcerative colitis, pouchitis and โ€ฆSee details»

Aesrx - Overview, News & Similar companies | ZoomInfo.com

Aesrx. Non-Profit & Charitable Organizations · Massachusetts, United States · 25 Employees. View Company Info for FreeSee details»

Baxter Acquires AesRx, LLC | Technology Networks

Jul 10, 2014 "By becoming a part of Baxter's organization, we believe this will provide Aes-103 the needed resources and expertise to complete a robust development and commercialization โ€ฆSee details»

Baxter announces acquisition of AesRx - Pharmaceutical Technology

Jul 10, 2014 AesRxโ€™s founder and former CEO Stephen Seiler said: "By becoming a part of Baxterโ€™s organization, we believe this will provide Aes-103 the needed resources and โ€ฆSee details»

AesRx - Company Profile - Tracxn

AesRx - Developing prophylactic treatment for sickle cell disease (SCD). Acquired by Baxter. Raised a total funding of $1.96M over 3 rounds. Founded by Steve Seiler in the year 2009. โ€ฆSee details»

Baxter : Acquires AesRx, LLC, Including Its Investigational Sickle โ€ฆ

Jul 9, 2014 ''By becoming a part of Baxterโ€™s organization, we believe this will provide Aes-103 the needed resources and expertise to complete a robust development and commercialization โ€ฆSee details»

AesRx LLC - Company Profile and News - Bloomberg Markets

Company profile page for AesRx LLC including stock price, company news, executives, board members, and contact informationSee details»

Baxter Acquires AesRx, LLC, Including Its ... - Fierce Biotech

Jul 9, 2014 Program Carries Potential to Address Significant Unmet Patient Need DEERFIELD, Ill.--Baxter International Inc. (BAX) today announced the acquisition of AesRx, LLC, a private โ€ฆSee details»

Baxter International acquires AesRx - 2014-07-09 - Crunchbase

Jul 9, 2014 Acquired Organization: AesRx AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, Aes-103 and Aes-210, which targets orphan diseases. โ€ฆSee details»

AesRx - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

Baxter Acquires AesRx For Sickle Cell Drug - Chemical

Jul 14, 2014 Baxter has acquired AesRx, a Newton, Mass.-based biotech firm focused on orphan diseases.Baxter gains Aes-103, a small molecule that targets the underlying โ€ฆSee details»

AesRx - Tech Stack, Apps, Patents & Trademarks - Crunchbase

AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, Aes-103 and Aes-210, which targets orphan diseases.See details»

Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell ...

Jul 9, 2014 Program Carries Potential to Address Significant Unmet Patient Need. DEERFIELD, IL., July 9, 2014 โ€“ Baxter International Inc. (NYSE:BAX) today announced the acquisition of โ€ฆSee details»

A E S T X - Crossword Clues | Wordplays.com

What is a Crossword Clue? According to The New York Times, a crossword clue is โ€œa hint that the solver must decipher to find the answer that is then entered into the puzzle grid.โ€Depending on โ€ฆSee details»

A state slogan: Donโ€™t - New York Times Crossword Answers

Sep 19, 2024 AESTX Go back to NYTimes September 20, 2024. Open the puzzle page to get help with other clues. Before each clue, we put the number & direction of it in the puzzle - for โ€ฆSee details»

AesRx - Contacts, Employees, Board Members, Advisors & Alumni

Organization. AesRx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor โ€ฆSee details»

linkstock.net © 2022. All rights reserved